{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T11:59:50Z","timestamp":1793361590324,"version":"4.5.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>\n                    The immunology of the ocular surface has an important role in maintaining homeostasis and in the etiopathogenesis of a number of diseases when dysregulated. This can result in damage to the cornea and ocular surface and loss of clarity and vision. As the entire ocular surface is linked via its epithelium, vascular supply, and innervation, changes across one aspect have tangible effects on the other. Immune cells residing on the ocular surface and those that traffic across the ocular surface interact with the structural tissues to release molecular factors and result in tissue response and disease. Studies in animal models and\n                    <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                    experiments along with\n                    <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                    studies on the human ocular surface have given newer insights with closer representation of actual health and disease. Some of the diseases which have been found to have a strong immunological basis include dry eye disease (DED) and Sjogren\u2019s syndrome, keratoconus, corneal graft rejection, autoimmune conditions such as peripheral ulcerative keratitis, and Stevens\u2013Johnson syndrome. The ocular surface immunology has unique patterns and signatures across different diseases. These give us an opportunity to understand the diseases better find newer targets for therapy and an opportunity to reduce visual morbidity. Clinically, we envisage a shift from steroids and broad action immunomodulators toward target specific drugs making personalized medicine and customized therapy the way forward.\n                  <\/jats:p>","DOI":"10.4103\/ijo.ijo_1721_24","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T09:02:24Z","timestamp":1743325344000},"page":"516-520","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Understanding the immunology of the ocular surface and its relevance to clinical practice"],"prefix":"10.4103","volume":"73","author":[{"given":"Sharon","family":"D\u2019Souza","sequence":"first","affiliation":[{"name":"Department of Cornea, Ocular Surface and Refractive Surgery, Narayana Nethralaya Eye Hospital, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Shetty","sequence":"additional","affiliation":[{"name":"Department of Cornea, Ocular Surface and Refractive Surgery, Narayana Nethralaya Eye Hospital, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaminathan","family":"Sethu","sequence":"additional","affiliation":[{"name":"GROW Laboratory, Narayana Nethralaya Foundation, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"R1-20260422","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.it.2017.11.007","article-title":"When clarity is crucial: Regulating ocular surface immunity","volume":"39","author":"Foulsham","year":"2018","journal-title":"Trends Immunol"},{"issue":"9","key":"R2-20260422","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1874364101509010049","article-title":"Ocular surface as barrier of innate immunity","volume":"15","author":"Bola\u00f1os-Jim\u00e9nez","year":"2015","journal-title":"Open Ophthalmol J"},{"key":"R3-20260422","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0161-6420(88)33228-8","article-title":"The immunoarchitecture of the normal human lacrimal gland. Relevancy for understanding pathologic conditions","volume":"95","author":"Wieczorek","year":"1988","journal-title":"Ophthalmology"},{"key":"R4-20260422","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/s41385-022-00551-6","article-title":"Mucosal immunology of the ocular surface","volume":"15","author":"de Paiva","year":"2022","journal-title":"Mucosal Immunol"},{"key":"R5-20260422","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/mi.2010.26","article-title":"Autoimmunity at the ocular surface: Pathogenesis and regulation","volume":"3","author":"Stern","year":"2010","journal-title":"Mucosal Immunol"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0304-3959(82)90092-6","article-title":"Density and organization of free nerve endings in the corneal epithelium of the rabbit","volume":"14","author":"R\u00f3zsa","year":"1982","journal-title":"Pain"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"8670280.","DOI":"10.1155\/2017\/8670280","article-title":"Effector and regulatory T cell trafficking in corneal allograft rejection","volume":"2017","author":"Amouzegar","year":"2017","journal-title":"Mediators Inflamm"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41586-020-2424-4","article-title":"Structural cells are key regulators of organ-specific immune responses","volume":"583","author":"Krausgruber","year":"2020","journal-title":"Nature"},{"key":"R9-20260422","doi-asserted-by":"crossref","first-page":"101090.","DOI":"10.1016\/j.preteyeres.2022.101090","article-title":"Corneal stromal repair and regeneration","volume":"91","author":"Mohan","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4103\/IJO.IJO_2986_22","article-title":"Ocular surface immune cell diversity in dry eye disease","volume":"71","author":"Nair","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"R11-20260422","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cts.12858","article-title":"Genistein-calcitriol mitigates hyperosmotic stress-induced TonEBP, CFTR dysfunction, VDR degradation and inflammation in dry eye disease","volume":"14","author":"Panigrahi","year":"2021","journal-title":"Clin Transl Sci"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.preteyeres.2012.02.003","article-title":"Ocular surface immunity: Homeostatic mechanisms and their disruption in dry eye disease","volume":"31","author":"Barabino","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"R13-20260422","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0022-1759(01)00407-0","article-title":"Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: Allergics vs. non-allergics","volume":"254","author":"Cook","year":"2001","journal-title":"J Immunol Methods"},{"key":"R14-20260422","doi-asserted-by":"crossref","first-page":"661.","DOI":"10.3390\/jcm11030661","article-title":"Influence of cytokines on inflammatory eye diseases: A citation network study","volume":"11","author":"G\u00e1lvez","year":"2022","journal-title":"J Clin Med"},{"key":"R15-20260422","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/282326a0","article-title":"Corneal allografts fail to express Ia antigens","volume":"282","author":"Streilein","year":"1979","journal-title":"Nature"},{"key":"R16-20260422","first-page":"186","article-title":"Corneal Langerhans cells and ocular immunology","volume":"4","author":"Jager","year":"1992","journal-title":"Reg Immunol"},{"key":"R17-20260422","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1167\/iovs.02-0838","article-title":"The corneal stroma is endowed with a significant number of resident dendritic cells","volume":"44","author":"Hamrah","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-20260422","first-page":"639","article-title":"Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells","volume":"43","author":"Hamrah","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R19-20260422","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1084\/jem.20010838","article-title":"Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts","volume":"195","author":"Liu","year":"2002","journal-title":"J Exp Med"},{"key":"R20-20260422","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/sj.eye.6700617","article-title":"Immune defense at the ocular surface","volume":"17","author":"Akpek","year":"2003","journal-title":"Eye (Lond)"},{"key":"R21-20260422","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1167\/iovs.19-26914","article-title":"Dysregulated tear fluid nociception-associated factors, corneal dendritic cell density, and vitamin D levels in evaporative dry eye","volume":"60","author":"Khamar","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R22-20260422","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/978-1-4615-0717-8_103","article-title":"Role of immunity and inflammation in corneal and ocular surface disease associated with dry eye","volume":"506","author":"Dana","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"R23-20260422","doi-asserted-by":"crossref","first-page":"19.","DOI":"10.1186\/s40662-016-0051-9","article-title":"Tear biomarkers for keratoconus","volume":"3","author":"Nishtala","year":"2016","journal-title":"Eye Vis (Lond)"},{"key":"R24-20260422","doi-asserted-by":"crossref","first-page":"e36451.","DOI":"10.1371\/journal.pone.0036451","article-title":"Human tears reveal insights into corneal neovascularization","volume":"7","author":"Zakaria","year":"2012","journal-title":"PLoS One"},{"key":"R25-20260422","first-page":"1449","article-title":"T-helper 17 lymphocytes in ocular cicatricial pemphigoid","volume":"15","author":"Lambiase","year":"2009","journal-title":"Mol Vis"},{"key":"R26-20260422","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jtos.2021.04.002","article-title":"Altered ocular surface immune cell profile in patients with dry eye disease","volume":"21","author":"Nair","year":"2021","journal-title":"Ocul Surf"},{"key":"R27-20260422","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4103\/IJO.IJO_3363_22","article-title":"Patient stratification using point of care biomarkers in dry eye disease","volume":"71","author":"Shetty","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"R28-20260422","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"R29-20260422","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","article-title":"The lack of association between signs and symptoms in patients with dry eye disease","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"key":"R30-20260422","first-page":"862","article-title":"Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease","volume":"16","author":"Enr\u00edquez-de-Salamanca","year":"2010","journal-title":"Mol Vis"},{"key":"R31-20260422","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","article-title":"The pathophysiology of dry eye disease: What we know and future directions for research","volume":"124","author":"Pflugfelder","year":"2017","journal-title":"Ophthalmology"},{"key":"R32-20260422","doi-asserted-by":"crossref","first-page":"2532314.","DOI":"10.1155\/2018\/2532314","article-title":"Innate and adaptive cell populations driving inflammation in dry eye disease","volume":"2018","author":"Reyes","year":"2018","journal-title":"Mediators Inflamm"},{"key":"R33-20260422","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1167\/iovs.08-2417","article-title":"Characterization of effector T cells in dry eye disease","volume":"50","author":"El Annan","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R34-20260422","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1080\/09273948.2017.1340486","article-title":"Assessment of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with dry eye disease","volume":"26","author":"Celik","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"R35-20260422","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.4103\/IJO.IJO_2981_22","article-title":"Tear biomarkers in dry eye disease: Progress in the last decade","volume":"71","author":"Kumar","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"R36-20260422","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/ICO.0000000000002954","article-title":"Clinical and molecular outcomes after combined intense pulsed light therapy with low-level light therapy in recalcitrant evaporative dry eye disease with meibomian gland dysfunction","volume":"41","author":"D\u2019Souza","year":"2022","journal-title":"Cornea"},{"key":"R37-20260422","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/09273948.2020.1780271","article-title":"Is keratoconus an inflammatory disease? The implication of inflammatory pathways","volume":"30","author":"Loh","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"R38-20260422","doi-asserted-by":"crossref","first-page":"20891.","DOI":"10.1038\/s41598-021-99805-9","article-title":"Keratoconus patients exhibit a distinct ocular surface immune cell and inflammatory profile","volume":"11","author":"D\u2019Souza","year":"2021","journal-title":"Sci Rep"},{"key":"R39-20260422","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/08820538.2013.825297","article-title":"Gene therapy in corneal transplantation","volume":"28","author":"Qazi","year":"2013","journal-title":"Semin Ophthalmol"},{"key":"R40-20260422","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00004397-200201000-00015","article-title":"Corneal graft rejection: Recent updates","volume":"42","author":"Tham","year":"2002","journal-title":"Int Ophthalmol Clin"},{"key":"R41-20260422","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/02713680701767884","article-title":"Immune mechanisms of corneal allograft rejection","volume":"32","author":"Niederkorn","year":"2007","journal-title":"Curr Eye Res"},{"key":"R42-20260422","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1755-3768.2009.01596.x","article-title":"The taming of the shrew?","volume":"87","author":"Pleyer","year":"2009","journal-title":"The immunology of corneal transplantation Acta Ophthalmol"},{"key":"R43-20260422","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.survophthal.2016.01.004","article-title":"Stevens-Johnson syndrome: The role of an ophthalmologist","volume":"61","author":"Jain","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"R44-20260422","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00417-014-2568-8","article-title":"Comprehensive approach to ocular consequences of Stevens Johnson Syndrome - the aftermath of a systemic condition","volume":"252","author":"Iyer","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R45-20260422","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/bjophthalmol-2017-310373","article-title":"Ocular surface cytokine profile in chronic Stevens-Johnson syndrome and its response to mucous membrane grafting for lid margin keratinisation","volume":"102","author":"Gurumurthy","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"R46-20260422","doi-asserted-by":"crossref","first-page":"18433.","DOI":"10.1038\/s41598-021-97575-y","article-title":"Differential expression of tear film cytokines in Stevens-Johnson syndrome patients and comparative review of literature","volume":"11","author":"Koduri","year":"2021","journal-title":"Sci Rep"},{"key":"R47-20260422","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jtos.2024.04.003","article-title":"Elevated neutrophils and reduced NK cells are associated with altered tear molecular signatures and clinical sequelae of chronic ocular Stevens-Johnson syndrome","volume":"34","author":"D\u2019Souza","year":"2024","journal-title":"Ocul Surf"},{"key":"R48-20260422","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.survophthal.2021.02.013","article-title":"Peripheral ulcerative keratitis","volume":"66","author":"Gupta","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"R49-20260422","doi-asserted-by":"crossref","first-page":"108458.","DOI":"10.1016\/j.exer.2021.108458","article-title":"Biology of peripheral ulcerative keratitis","volume":"204","author":"Gomes","year":"2021","journal-title":"Exp Eye Res"},{"key":"R50-20260422","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4103\/ijo.IJO_2016_20","article-title":"Update on ocular graft-versus-host disease","volume":"69","author":"Nair","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R51-20260422","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jtos.2018.12.007","article-title":"Marked infiltration of neutrophils at the upper palpebral conjunctiva in patients with chronic graft-versus-host disease","volume":"17","author":"Byun","year":"2019","journal-title":"Ocul Surf"},{"key":"R52-20260422","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.2147\/OPTH.S279051","article-title":"A review of the mechanism of action of cyclosporine A: The role of cyclosporine A in dry eye disease and recent formulation developments","volume":"14","author":"Periman","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"R53-20260422","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/0976-500X.195920","article-title":"Lifitegrast: A novel drug for treatment of dry eye disease","volume":"7","author":"Abidi","year":"2016","journal-title":"J Pharmacol Pharmacother"},{"key":"R54-20260422","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jamaophthalmol.2013.195","article-title":"Topical interleukin 1 receptor antagonist for treatment of dry eye disease: A randomized clinical trial","volume":"131","author":"Amparo","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R55-20260422","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jtos.2019.10.004","article-title":"Pathological consequences of anti-citrullinated protein antibodies in tear fluid and therapeutic potential of pooled human immune globulin-eye drops in dry eye disease","volume":"18","author":"Kwon","year":"2020","journal-title":"Ocul Surf"},{"key":"R56-20260422","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/bph.12138","article-title":"Twenty-first century mast cell stabilizers","volume":"170","author":"Finn","year":"2013","journal-title":"Br J Pharmacol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_1721_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:58:08Z","timestamp":1786647488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_1721_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1721_24","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"2024-07-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}